Ng George K's Form 4/A amendment
AmendedProcessa Pharmaceuticals, Inc. (PCSA) · filed Apr 30, 2026
- Accession no.
- 0000897069-26-000979
- Filed
- Apr 30, 2026
- Trade date
- Apr 15, 2026
- Filing delay
- 15 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Apr 17, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $5.47K. It was filed 15 days after the trade.
This filing was later replaced by the amendment 0000897069-26-001167 (May 19, 2026). Trade tables on this site use the amended version.
This amendment replaces 0000897069-26-000910 (filed Apr 17, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ng George KCIK 0001638744 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | PPurchaseAcquired | +1,843 | $2.97 | +$5,473.71 | 3,979 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.